John M. Bennett
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 219
- Acute Myeloid Leukemia Research 195
- Chronic Myeloid Leukemia Treatments 34
- Genetics 116
- Chronic Lymphocytic Leukemia Research 64
- Myeloproliferative Neoplasms: Diagnosis and Treatment 48
- Co-authors
- Georges Flandrin (9 shared papers)C. Sultan (7 shared papers)Daniel Catovsky (8 shared papers)H. R. Gralnick (7 shared papers)D. A. G. Galton (3 shared papers)MT Daniel (4 shared papers)Guillermo Sanz (9 shared papers)Peter L. Greenberg (14 shared papers)
- Journals
- Blood (44 papers)Leukemia Research (42 papers)Cancer (28 papers)British Journal of Haematology (21 papers)Journal of Clinical Oncology (20 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
John M. Bennett
381 papers receiving 39.6k citations
John M. Bennett's Hit Papers
Peers
Comparison fields: 5 of 202
- Hematology 28.8k
- Genetics 11.2k
- Emergency Medicine 3.5k
- Public Health, Environmental and Occupational Health 8.3k
- Immunology 5.2k
Countries citing papers authored by John M. Bennett
This map shows the geographic impact of John M. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Bennett more than expected).
Fields of papers citing papers by John M. Bennett
This network shows the impact of papers produced by John M. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Bennett. The network helps show where John M. Bennett may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Bennett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 396 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Proposals for the Classification of the Acute Leukaemias F Hit paper breakdown → | 1976 | 4454 |
| 2 | International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes Hit paper breakdown → | 1997 | 3200 |
| 3 | Proposals for the classification of the myelodysplastic syndromes Hit paper breakdown → | 1982 | 2952 |
| 4 | Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia Hit paper breakdown → | 1985 | 2418 |
| 5 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 1873 |
| 6 | Prognostic effect of weight loss prior tochemotherapy in cancer patients Hit paper breakdown → | 1980 | 1785 |
| 7 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study Hit paper breakdown → | 2009 | 1756 |
| 8 | Decitabine improves patient outcomes in myelodysplastic syndromes Hit paper breakdown → | 2006 | 1139 |
| 9 | Proposals for the classification of the myelodysplastic syndromes Hit paper breakdown → | 1982 | 993 |
| 10 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion Hit paper breakdown → | 2006 | 893 |
| 11 | Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases Hit paper breakdown → | 1981 | 745 |
| 12 | Diagnostic criteria and classification of mastocytosis: a consensus proposal Hit paper breakdown → | 2001 | 738 |
| 13 | Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Hit paper breakdown → | 2001 | 654 |
| 14 | Anthracycline Dose Intensification in Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 639 |
| 15 | Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. Hit paper breakdown → | 1989 | 565 |
| 16 | Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7) Hit paper breakdown → | 1985 | 559 |
| 17 | Report of an international working group to standardize response criteria for myelodysplastic syndromes. Hit paper breakdown → | 2000 | 524 |
| 18 | Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) Hit paper breakdown → | 1991 | 514 |
| 19 | 1998 | 446 | |
| 20 | The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations Hit paper breakdown → | 1981 | 385 |
About John M. Bennett
John M. Bennett is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 396 papers that have together received 41.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (195 papers), Chronic Lymphocytic Leukemia Research (64 papers), Acute Lymphoblastic Leukemia research (60 papers), Lymphoma Diagnosis and Treatment (54 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (48 papers), Chronic Myeloid Leukemia Treatments (34 papers), Hematological disorders and diagnostics (31 papers) and Retinoids in leukemia and cellular processes (29 papers). The work is most often cited by research in Hematology (28.8k citations), Genetics (11.2k citations), Emergency Medicine (3.5k citations), Public Health, Environmental and Occupational Health (8.3k citations) and Immunology (5.2k citations). John M. Bennett has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Georges Flandrin, C. Sultan, Daniel Catovsky, H. R. Gralnick, D. A. G. Galton, MT Daniel, Guillermo Sanz, Peter L. Greenberg, Pierre Fenaux and Martin S. Tallman. Their work appears in journals such as Blood, Leukemia Research, Cancer, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.